Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Regulators probe J&J’s marketing of recalled hip implants
Federal investigators investigate Johnson & Johnson and its DePuy Orthopaedics subsidiary for possible violations in marketing the recalled ASR hip implants.
2. Details on the FDA panel’s NeuroPace deliberations
More data is needed on who should implant NeuroPace’s deep-brain stimulation therapy for epilepsy, including who should get the implant and where the procedure should occur, according to an FDA advisory panel.
1. FDA hits DePuy with Class 1 recall over joint sleeve
DePuy pulls a joint surgery component off the market in a move the FDA termed a Class I recall, its most serious designation.
